ShadowBuys
Sign inJoin for free

Gilead Sciences (GILD)

Healthcare · Drug Manufacturers - General

20 members of Congress have disclosed 72 trades in Gilead Sciences (GILD) since 2014: 43 buys and 29 sales. The most recent was disclosed on Jul 21, 2026. 1 trade was made by members of a committee that oversees Gilead Sciences's industry.

Trades disclosed
72
Members trading
20
Buys / sells
43 / 29
Reported value
$345K–$1.6M

Keep following the company.

Subscribers get new congressional filings and notable insider purchases for companies they follow. Coverage varies by company.

Follow GILD

What else is happening at GILD

All research →

Company filings and public records connected to this stock, ordered by when they became public or were first observed.

  1. GILDFinancial report·SEC EDGAR

    GILD: 10-Q financial filing

    Filed 10-Q for an event or period dated 2026-09-30. Read the company report for its disclosures.

    Public: Oct 29, 2026, 8:09 PM EDTEvent / period: Sep 30, 2026Original source ↗
  2. GILDCompany announcement·SEC EDGAR

    GILD: Financial results

    Filed 8-K for an event or period dated 2026-10-29. Financial results.

    Public: Oct 29, 2026, 4:03 PM EDTEvent / period: Oct 29, 2026Original source ↗

Committee overlaps

Trades by members of a committee that oversees Gilead Sciences's industry. An overlap is a fact about the trade, not evidence of wrongdoing.

Who traded GILD

All trades

From periodic transaction reports filed under the STOCK Act. Amounts are the ranges members report, and trades can be disclosed up to 45 days after they happen. Nothing here is investment advice.